"Efficacy and Safety of Vismodegib" Report Released

Last Updated on Wednesday, 03 February 2016 14:11
Published on Friday, 08 June 2012 20:02
Hits: 4272

The New England Journal of Medicine yesterday released a report on the "Efficacy and Safety of Vismodegib in advanced Basal Cell Carcinoma".

Following a clinical trial for the treatment of basal cell carcinomas in the USA the findings were published yesterday.   Vismodegib is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma.  A summary of the report can be viewed at The New England Journal of Medicine.